Linked Data API

Show Search Form

Search Results

1713932
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Clinical Trials more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the paper entitled The Future of Clinical Research Delivery: 2022 to 2025 implementation plan, published on 30 June 2022, what progress has been made on the Find, Recruit and Follow-up service for clinical trials. more like this
tabling member constituency Newcastle upon Tyne Central remove filter
tabling member printed
Chi Onwurah remove filter
uin 23739 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-30more like thismore than 2024-04-30
answer text <p>Since publication of the Future of Clinical Research Delivery, we have developed early versions of several products as part of the Find, Recruit and Follow-up Service, to deliver secure data enabled study feasibility and recruitment within established governance and legal requirements, across England and other parts of the United Kingdom.</p><p> </p><p>These products include: NHS England’s DigiTrials self-service feasibility tool, which identifies suitable locations for studies by establishing where the largest groupings of eligible people are based; NHS England’s DigiTrials recruitment service, which is currently in its second phase of pilots and will enable the National Health Service to more easily approach patients about research relevant to them; the Medicines and Healthcare products Regulatory Agency’s Clinical Research Practice Datalink, which allows participating general practices to identify potentially eligible patients for relevant studies more easily; and the Be Part of Research registry, which allows people to proactively register their interest in participating in research.</p><p> </p><p>These tools have been developed to increase the efficiency and effectiveness of the clinical research process, and also improve our ability to widen access to research opportunities, increase the resilience and sustainability of the healthcare system, and reduce the burden on the NHS workforce.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-04-30T10:48:51.65Zmore like thismore than 2024-04-30T10:48:51.65Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4124
label Biography information for Chi Onwurah more like this
1713933
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Clinical Trials: Contracts more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled Full government response to the Lord O'Shaughnessy review into commercial clinical trials, last updated on 8 December 2023, what her Department's planned timetable is for expanding the national contract value review programme to phase 1 and 2a clinical trials. more like this
tabling member constituency Newcastle upon Tyne Central remove filter
tabling member printed
Chi Onwurah remove filter
uin 23740 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-30more like thismore than 2024-04-30
answer text <p>The National Contract Value Review (NCVR) process applies to commercial clinical studies. NHS England is working in partnership with the devolved administrations, the National Institute for Health and Care Research, and other partners, to pilot the use of the NCVR process for phase I and IIa of commercial clinical trials. The ambition is to make the use of NCVR for phase I and IIa of commercial clinical trials mainstream from October 2024.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-04-30T09:57:50.757Zmore like thismore than 2024-04-30T09:57:50.757Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4124
label Biography information for Chi Onwurah more like this